The World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC), now in its 22nd year, is a unique and exciting multidisciplinary CME meeting. It has become the premier global meeting dedicated to diabetes, obesity, lipids, cardiovascular renal and hepatic diseases, linking basic research with clinical practice to fulfill our theme: Exploring New Frontiers in Metabolism - Tomorrow's Clinical Science Today.

WCIRDC 2024 will be held on-site December 12-14, 2024 at the Hilton Universal Studios Hotel in Los Angeles.

WCIRDC is the only major conference that combines basic and clinical science. For nearly two decades, it has brought together researchers, physicians, clinicians, and other healthcare professionals in a unique international program that takes the latest developments from the lab to the clinic and back again.” I first heard about this at the conference” is a frequent comment from audience members.WCIRDC provides attendees with a unique experience of interacting with distinguished faculty from around the world. In an intimate setting, the collaborative experience explores the latest understanding of metabolic diseases and the development of future therapeutic modalities.

Since Dr. Gerald Reaven's pioneering work clarifying the relationship between insulin resistance (IR), diabetes, obesity, and cardiovascular disease, the focus of the Congress has expanded to include kidney, liver, brain, bone, cancer, and more. The congress addressed dyslipidemia,:atherosclerosis, hypertension, hypercoagulable states, inflammation and energy metabolism. It provided the latest clinical updates on pharmacologic interventions such as GLP1ra, SGLT21, PCSK9i, MRA and EPA to name a few. The daily goal is to understand state-of-the-art pathophysiology and new medical interventions and to develop appropriate integrated clinical management strategies.

In order to make basic and clinical research topics relevant to clinical medicine, each session will be followed by a live Q&A and discussion on the impact of clinical practice. To promote greater interaction with faculty and provide further insights, each day will end with an hour-long live panel discussion providing a summary of the day, commentary, and Q&A.

The conference will attract top researchers, emerging researchers and established leaders from around the world to submit abstracts of their latest papers. Abstracts will be published in the peer-reviewed journal Metabolism and will be available on demand for 90 days.

The conference was covered by numerous media outlets and the proceedings were published on global medical news sites such as Healio, Medscape, Endocrinology & Cardiology Today, Clinical Endocrinology News, Practical Cardiology, HCP Live, etc. The proceedings of the conference were published on global medical news websites such as Healio, Medscape, Endocrinology & Cardiology Today, Clinical Endocrinology News, Practical Cardiology, HCP Live, etc., while articles were published in peer-reviewed journals such as The Journal of Diabetes Mellitus, Endocrine Practice, Metabolism, Diabetes & Vascular Disease Research and Diabetes & its Complications.